Cargando…

Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism

In this study we present a method using whole cell MALDI-TOF MS and VITEK MS RUO/SARAMIS as a rapid epidemiological screening tool. MRSA was used as a model organism for setting up the screening strategy. A collection of well-characterised MRSA strains representing the 19 most common Pulsed-Field Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindgren, Åsa, Karami, Nahid, Karlsson, Roger, Åhrén, Christina, Welker, Martin, Moore, Edward R. B., Stadler, Liselott Svensson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748427/
https://www.ncbi.nlm.nih.gov/pubmed/28924947
http://dx.doi.org/10.1007/s10096-017-3101-x
_version_ 1783289396500365312
author Lindgren, Åsa
Karami, Nahid
Karlsson, Roger
Åhrén, Christina
Welker, Martin
Moore, Edward R. B.
Stadler, Liselott Svensson
author_facet Lindgren, Åsa
Karami, Nahid
Karlsson, Roger
Åhrén, Christina
Welker, Martin
Moore, Edward R. B.
Stadler, Liselott Svensson
author_sort Lindgren, Åsa
collection PubMed
description In this study we present a method using whole cell MALDI-TOF MS and VITEK MS RUO/SARAMIS as a rapid epidemiological screening tool. MRSA was used as a model organism for setting up the screening strategy. A collection of well-characterised MRSA strains representing the 19 most common Pulsed-Field Gel Electrophoresis (PFGE)-types in the region of South-West Sweden for the past 20 years was analysed with MALDI-TOF MS. A total of 111 MRSA strains were used for creating 19 PFGE-specific Superspectra using VITEK MS RUO/SARAMIS. Prior to performing the final analysis, the 19 Superspectra were combined into ten groups displaying similar peak patterns, hereafter named “MALDI-types”. Two-hundred fifty-five MRSA strains were analysed to test the constructed Superspectra/MALDI-type database. Matches to the Superspectra above a threshold of 65% (corresponding to the number of matched peaks in the Superspectrum) were considered as positive assignment of a strain to a MALDI-type. The median peak matching value for correct assignment of a strain to a MALDI-type was 78% (range 65.3–100%). In total, 172 strains (67.4%) were assigned to the correct MALDI-type and only 5.5% of the strains were incorrectly assigned to another MALDI-type than the expected based on the PFGE-type of the strain. We envision this methodology as a cost-efficient step to be used as a first screening strategy in the typing scheme of MRSA isolates, to exclude epidemiological relatedness of isolates or to identify the need for further typing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10096-017-3101-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5748427
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-57484272018-01-19 Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism Lindgren, Åsa Karami, Nahid Karlsson, Roger Åhrén, Christina Welker, Martin Moore, Edward R. B. Stadler, Liselott Svensson Eur J Clin Microbiol Infect Dis Original Article In this study we present a method using whole cell MALDI-TOF MS and VITEK MS RUO/SARAMIS as a rapid epidemiological screening tool. MRSA was used as a model organism for setting up the screening strategy. A collection of well-characterised MRSA strains representing the 19 most common Pulsed-Field Gel Electrophoresis (PFGE)-types in the region of South-West Sweden for the past 20 years was analysed with MALDI-TOF MS. A total of 111 MRSA strains were used for creating 19 PFGE-specific Superspectra using VITEK MS RUO/SARAMIS. Prior to performing the final analysis, the 19 Superspectra were combined into ten groups displaying similar peak patterns, hereafter named “MALDI-types”. Two-hundred fifty-five MRSA strains were analysed to test the constructed Superspectra/MALDI-type database. Matches to the Superspectra above a threshold of 65% (corresponding to the number of matched peaks in the Superspectrum) were considered as positive assignment of a strain to a MALDI-type. The median peak matching value for correct assignment of a strain to a MALDI-type was 78% (range 65.3–100%). In total, 172 strains (67.4%) were assigned to the correct MALDI-type and only 5.5% of the strains were incorrectly assigned to another MALDI-type than the expected based on the PFGE-type of the strain. We envision this methodology as a cost-efficient step to be used as a first screening strategy in the typing scheme of MRSA isolates, to exclude epidemiological relatedness of isolates or to identify the need for further typing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10096-017-3101-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-09-18 2018 /pmc/articles/PMC5748427/ /pubmed/28924947 http://dx.doi.org/10.1007/s10096-017-3101-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Lindgren, Åsa
Karami, Nahid
Karlsson, Roger
Åhrén, Christina
Welker, Martin
Moore, Edward R. B.
Stadler, Liselott Svensson
Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
title Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
title_full Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
title_fullStr Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
title_full_unstemmed Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
title_short Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism
title_sort development of a rapid maldi-tof ms based epidemiological screening method using mrsa as a model organism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748427/
https://www.ncbi.nlm.nih.gov/pubmed/28924947
http://dx.doi.org/10.1007/s10096-017-3101-x
work_keys_str_mv AT lindgrenasa developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism
AT karaminahid developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism
AT karlssonroger developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism
AT ahrenchristina developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism
AT welkermartin developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism
AT mooreedwardrb developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism
AT stadlerliselottsvensson developmentofarapidmalditofmsbasedepidemiologicalscreeningmethodusingmrsaasamodelorganism